MindWalk Holdings Corp. (HYFT)
1.70
-0.02
(-1.16%)
USD |
NASDAQ |
Dec 26, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 78.46M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 324.7% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 5.016 |
| Price to Book Value | 6.209 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.2049 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 98.24% |
Profile
| MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. It operates through the following geographical segments: United States of America, Europe, Canada, Australia, and Other. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX. |
| URL | http://www.ipatherapeutics.com |
| Investor Relations URL | https://ir.ipatherapeutics.com/overview/default.aspx |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Mar. 26, 2026 (est.) |
| Last Earnings Release | Dec. 15, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. It operates through the following geographical segments: United States of America, Europe, Canada, Australia, and Other. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX. |
| URL | http://www.ipatherapeutics.com |
| Investor Relations URL | https://ir.ipatherapeutics.com/overview/default.aspx |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Mar. 26, 2026 (est.) |
| Last Earnings Release | Dec. 15, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |